> ## Documentation Index
> Fetch the complete documentation index at: https://docs.getrivet.ca/llms.txt
> Use this file to discover all available pages before exploring further.

# PHQ-9 — Patient Health Questionnaire

> The standard depression severity scale. 9 items, 0–27 total, severity bands from Minimal to Severe, with Item 9 risk flagging for suicidal ideation.

The PHQ-9 is the dominant standardized depression-severity screening
instrument in primary care, mental health, and outcome-informed therapy.
If you administer one depression measure, it's almost always this one.

## What it measures

Depression severity over the last two weeks, mapped to DSM-5 Major
Depressive Disorder criteria. Nine symptom items — anhedonia, depressed
mood, sleep, fatigue, appetite, guilt/worthlessness, concentration,
psychomotor agitation/retardation, and suicidal ideation. Each item is
rated on a 4-point frequency scale.

A tenth item captures functional impairment but is not included in the
total score — it's there for context, not for the band.

## When to use it

* **Intake.** As a baseline measure on the first session — typically sent
  async ahead of time.
* **Every 2–4 weeks during treatment.** To track response without
  screening burnout.
* **Pre/post a discrete intervention.** Around a CBT protocol, an EMDR
  reprocessing target, or a medication change.
* **Discharge.** Outcome documentation.

Pairs naturally with the [GAD-7](/clinical-templates/screening/gad-7) as
the standard depression-anxiety baseline.

## How clients fill it

Two minutes on a phone, slightly less on a laptop. The 2-week stem
prompt appears at the top — "Over the last 2 weeks, how often have you
been bothered by any of the following problems?" — followed by the nine
items, each with the same four-option frequency scale:

* Not at all
* Several days
* More than half the days
* Nearly every day

Item 10 (functional impairment) uses a different four-option scale (Not
difficult at all → Extremely difficult) and is shown for context.

## How Rivet scores it

Each of the four response options carries a score:

* Not at all → 0
* Several days → 1
* More than half the days → 2
* Nearly every day → 3

The total is the sum of items 1–9. Item 10 is not summed into the total.
Range: 0–27.

The score appears live in your scoring pill as the client answers — you
see the running total and the current severity band update with each tap.

## Severity bands

| Total | Severity          |
| ----- | ----------------- |
| 0–4   | Minimal           |
| 5–9   | Mild              |
| 10–14 | Moderate          |
| 15–19 | Moderately severe |
| 20–27 | Severe            |

A score of 10 or higher is the screening threshold widely cited for
further evaluation of major depression (Kroenke 2001).

## Clinical change

A drop of 5 points on the PHQ-9 is the convention most often cited as
clinically meaningful improvement (per the follow-up literature around
Kroenke et al.). This is a clinical convention, not a Rivet calculation —
the in-session scoring pill shows the current total only. If you want
to compare two PHQ-9s administered weeks apart, you're reading them off
your chart.

## Item 9 — suicidal ideation

<Warning>
  **Any positive answer on Item 9 warrants suicide-risk follow-up
  regardless of the total score.** A PHQ-9 of 6 with Item 9 answered
  "Several days" matters more than a PHQ-9 of 22 with Item 9 at zero.

  Rivet surfaces a flag in the scoring pill when Item 9 is above zero.
  The clinical decision about what to do next — safety planning, C-SSRS,
  consult, hospitalization, all of the above — is yours.
</Warning>

Item 9 reads: "Thoughts that you would be better off dead, or of hurting
yourself in some way." A "Several days" answer means the thoughts were
present on several days in the past two weeks, which is a clinically
significant signal even at low frequency.

## Using it in a Canadian practice

**No licence, no fee.** The PHQ-9 is free to use in clinical practice and you
don't need permission to administer it — whether you send it ahead of a session
or run it on the call.

**Your client's answers stay in Canada.** A completed PHQ-9 is health
information about a named person. The answers are stored encrypted in a Montreal
data centre and land in that client's chart against the session they belong to.
Nothing goes to an outside service to be scored — the severity band and the Item
9 flag are computed from the answers themselves.

**Getting it into your file of record.** The scored result copies out formatted
for a progress note, so it pastes into Jane, Owl or whatever holds the record.
You're not retyping a total, and the band travels with it.

**What you document is yours.** Rivet flags a positive Item 9 and timestamps
when the response came in. What your College expects you to record about that —
and what you do next — sits with you.

**English only.** Validated French translations of the PHQ-9 exist, but the
version here is English. If you practise in French, you'll be working from your
own copy for that client.

## When NOT to use it

* **Clients under 18.** The PHQ-9 was validated in adults. For
  adolescents, the PHQ-A is the age-appropriate version.
* **As a sole diagnostic instrument.** The PHQ-9 is a screening measure.
  A score of 22 doesn't diagnose Major Depressive Disorder; the clinical
  interview does.
* **As an outcome measure on its own without paired anxiety screening.**
  Comorbidity is the rule, not the exception — pairing with GAD-7 catches
  the common presentation that PHQ-9 alone would miss.

## PHQ-9 vs the other depression measures

The PHQ-9 is the default. The others earn their place in specific
situations.

* **vs [QIDS-SR-16](/clinical-templates/screening/qids-sr-16)** — the QIDS
  spreads sixteen items across the DSM symptom domains, giving sleep four
  items and appetite four where the PHQ-9 gives each one. Reach for it when
  you want that resolution; reach for the PHQ-9 when you want the measure a
  referrer will recognise without explanation.
* **vs [CES-D-R](/clinical-templates/screening/ces-d-r)** — twenty items, a
  past-week frame rather than two weeks, and two separate suicidality items
  instead of the PHQ-9's single Item 9. Often chosen for continuity when a
  client already has older CES-D scores in their file.
* **vs [WHO-5](/clinical-templates/screening/who-5)** — five items about
  well-being rather than symptoms. Useful with a client who bristles at
  problem-framed questionnaires, but a low WHO-5 is the signal to follow up
  with a PHQ-9, not a substitute for one.
* **vs [PHQ-A](/clinical-templates/child/phq-a)** — the same nine symptoms in
  adolescent wording, for ages 11–17, scored against a cutoff of 11 rather
  than 10. Use it for anyone under 18.
* **vs the BDI-II** — the Beck Depression Inventory is a licensed instrument
  sold by Pearson and paid for per use. Rivet doesn't include it, and that
  was deliberate: the library was built from measures you can administer
  without a per-administration fee. If your practice already licenses the
  BDI-II, you'll keep running it wherever you licensed it.

## Citation

Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2001). "The PHQ-9:
Validity of a brief depression severity measure." *Journal of General
Internal Medicine*, 16(9): 606–613.

Copyright Pfizer Inc. Explicitly released by Pfizer in 2010 for free
public use without restriction. Rivet preserves the canonical item
wording verbatim — paraphrase would break instrument validity, because
the published severity bands only apply to the published item wording.

## Related articles

<CardGroup cols={2}>
  <Card title="GAD-7" icon="chart-column" href="/clinical-templates/screening/gad-7">
    The companion anxiety measure — administered alongside PHQ-9 as the
    standard baseline.
  </Card>

  <Card title="Screening overview" icon="clipboard-check" href="/clinical-templates/screening/overview">
    When to screen, picking between overlapping depression measures, and
    the risk-flag rule.
  </Card>

  <Card title="Filling a template in-session" icon="users" href="/clinical-templates/in-session-administration">
    The live collaborative flow you'll use when administering this measure.
  </Card>
</CardGroup>
